PATENT CLAIM ANALYSIS

Application Number: 16120170
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["544", "324000"]

Abstract:
A compound of formula (I), or a pharmaceutically acceptable salt thereof, for use in the treatment of autoimmune diseases and inflammatory conditions.

Claim (Index 51):
The method as claimed in  claim 50  wherein the condition is selected from the group consisting of rheumatoid arthritis, systemic lupus erythematosus, Crohn's disease, multiple sclerosis, rejection after organ transplantation and atherosclerosis.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 96.0
- Lexical Diversity: 1.08
- Patent Class: 544.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15447818', '14647400', '15899061', '15315461', '15315478']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8400079952039953
- 35 USC 102 Novelty (BERT): 0.5766101756793245
- Combined Prediction Score: 0.8136682132515282
- Mean Citation Score: 477.80761600000005
- Max Citation Score: 496.26343
- Similarity Product: 396.4458090312374

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test